NCT07363070

Brief Summary

To describe the adherence to positive airway pressure therapy among obese adult patients refered to the respiratory center east

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 2, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 23, 2026

Completed
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

4.2 years

First QC Date

January 2, 2026

Last Update Submit

January 15, 2026

Conditions

Sleep Disorder; Breathing-RelatedObesityAdherence, Treatment

Outcome Measures

Primary Outcomes (1)

  • Compliance to noninvasive positive airway pressure therapy (nPAP) - 90 days

    Use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period within the first 90 days of having the equipment.

    0-3 months after start of noninvasive positive airway pressure therapy

Secondary Outcomes (2)

  • Mortality

    1 year

  • Compliance to noninvasive positive airway pressure therapy (nPAP) - 1 year

    Time Frame: 275 to 365 day after start of noninvasive positive airway pressure therapy

Interventions

Positive Airway Pressure TherapyDEVICE

Use of Positive Airway Pressure Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Respiratory center east,

You may qualify if:

  • years or older
  • Body mass index above 30 kg/m2
  • Referred to the Respiratory Center East between january 2021 and january 2024

You may not qualify if:

  • Neuromuscular disease
  • Spinal cord injury
  • Craniofacial malformation
  • Scoliosis
  • Diaphragmatic paresis
  • Referred to profylactic secrete management only
  • Already in treatment with nPAP with use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period during the last 90 days.
  • No medical indication for start of nPAP.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Respiratory Center East, Rigshospitalet

Glostrup Municipality, 2600, Denmark

Location

MeSH Terms

Conditions

Sleep Wake DisordersObesityTreatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightHealth BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

January 2, 2026

First Posted

January 23, 2026

Study Start

January 1, 2021

Primary Completion

April 1, 2025

Study Completion

January 1, 2026

Last Updated

January 23, 2026

Record last verified: 2026-01

Locations

DK(1)